Description
Follistatin Upregulation Complex
YK-11 represents a fundamentally different approach to muscle building—functioning as both a SARM and a myostatin inhibitor removing the biological brake your body places on muscle mass.
The Mechanism
YK-11 is a synthetic steroidal SARM structurally derived from dihydrotestosterone, but with altered downstream activity that separates it from traditional androgens. Unlike full AR agonists, YK-11 functions as a partial agonist that doesn’t interact within the androgen receptor in typical fashion. Instead, its primary mechanism involves dramatically increasing follistatin expression. Follistatin expression significantly upregulated key myogenic regulatory factors including MyoD, Myf5, and myogenin—transcription factors governing muscle differentiation and growth.
Anabolic Capacity
By removing myostatin’s natural ceiling on muscle growth, YK-11 allows muscle cells to continue proliferating and differentiating beyond what genetic programming typically permits. This dual mechanism—partial AR activation combined with myostatin suppression—creates an environment where muscles can bypass natural growth plateaus. The compound promotes accelerated skeletal muscle hypertrophy through follistatin-mediated myostatin inhibition while simultaneously driving protein synthesis and nitrogen retention through AR signaling. YK-11 doesn’t just build muscle, it removes the genetic governor.
This is not anabolic enhancement, it’s genetic limit disruption —
There are no reviews yet.